Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients

Abstract

In RRMS patients treated with IFN-beta the MRI changes occurring during the first year may have a prognostic value for identifying patients with a confirmed increase of disability after 2 years of therapy.